Clinical trial
Gallium-68 DOTATOC for Management of Neuroendocrine Tumors
NCT02375464 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gallium-68 DOTATOC for Management of Neuroendocrine Tumors
- Lead sponsor
- Northwell Health
- Phase
- Expanded access
- Overall status
- No longer available
- Start date
- April 30, 2015
- Completion date
- December 31, 2019
- Enrollment
- Not reported
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.